Task: Answer the MCQ question.
Query: Which drug exhibits a 9.466% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CCC(CC)c1nnc(NC(=O)CCN2C(=O)c3ccccc3C2=O)s1
b. CN(C)c1ccc(C(=O)NCC(c2cccs2)N2CCOCC2)cc1[N+](=O)[O-]
c. CC(=O)N1CCN(c2ccc(NC(=O)c3cc4ccccc4o3)cc2)CC1
Answer: a. CCC(CC)c1nnc(NC(=O)CCN2C(=O)c3ccccc3C2=O)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(CC)c1nnc(NC(=O)CCN2C(=O)c3ccccc3C2=O)s1
CCC(CC)c1nnc(NC(=O)CCN2C(=O)c3ccccc3C2=O)s1
3-(1,3-dioxoisoindol-2-yl)-N-(5-pentan-3-yl-1,3,4-thiadiazol-2-yl)propanamide